 Myriad Genetics, Inc. NASDAQ:MYGN Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Nathan Smith - Senior Vice President, Investor Relations Paul Diaz - President Chief Executive Officer Bryan Riggsbee - Chief Financial Officer Nicole Lambert - Chief Operating Officer Conference Call Participants Jack Meehan - Nephron Research Kyle Boucher - Cowen Operator Greetings and welcome to the Myriad Genetics First Quarter 2022 Financial Earnings Call. During the presentation, all participants will be in a listen-only mode. 